Is heparin contraindicated in pelvic lymphadenectomy and radical prostatectomy?
OBJECTIVE
We initiated a prospective study to verify or refute the complications of lymphocele formation and excessive blood loss associated with heparin prophylaxis in pelvic lymphadenectomy and radical prostatectomy.


METHODS
A prospective study was completed on 579 men undergoing pelvic lymphadenectomy usually in association with radical prostatectomy. Patients were assigned to group 1 (given preoperative and postoperative subcutaneous heparin) and group 2 (no heparin). All patients were evaluated 2 to 3 weeks after surgery with ultrasound for pelvic lymphocele.


RESULTS
There was no statistically significant difference in the number or size of pelvic lymphoceles or blood loss in group 1 versus group 2.


CONCLUSIONS
The use of heparin prophylaxis to prevent thromboembolic complications in conjunction with pelvic lymphadenectomy and radical prostatectomy is not associated with increased blood loss or increased rate of lymphocele formation.
Sieber
P R
PR
Urological Associates of Lancaster, Ltd., Pennsylvania, USA.
Rommel
F M
FM
Agusta
V E
VE
Breslin
J A
JA
Harpster
L E
LE
Huffnagle
H W
HW
Stahl
C
C
D016063:Blood Loss, Surgical; D000075202:Contraindications; D005343:Fibrinolytic Agents; D006493:Heparin; D006801:Humans; D008197:Lymph Node Excision; D008210:Lymphocele / Q000139:chemically induced* / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000139:chemically induced* / Q000453:epidemiology; D011446:Prospective Studies; D011468:Prostatectomy
D005343:Fibrinolytic Agents; D006493:Heparin